Nobody can explain exactly why Evans got any point wrong. However:
He missed the significance of Baby I's s maltophilia colonisation, a pathogen which has become much more of a problem at hospitals over the last decade or so, with alerts and descriptions in the literature.
He worked before better testing methods revealed higher than suspected incidence of enterovirus, particularly in infants. Enterovirus is the explanation the expert panel proposes for Band G's deterioration.
He was unaware until after the trial, by his own admission, that there were separate, forensic tests to detect exogenous insulin.
He retired just around the time when there was sweeping revision to guidance for recognizing and treating neonatal sepsis, which would have corroborated, for example, Mike Hall's concerns about Baby O's treatment and could have prompted concerns about Baby I's treatment with broad spectrum antibiotics.
He seems to have been unfamiliar with the respiratory monitors used at Chester, suggesting that they could have been switched off unnoticed when in fact they would show a countdown before restarting. I suspect such monitors were rarer in time.
Not insuperable obstacles with research and investment of energy, but this sort of thing, mixed with the different demographics and treatments others have discussed, mean that a lot of his knowledge and experience from before 2001 would not have been directly transferable.